Ligand Pharmaceuticals Statistics
Total Valuation
BOM:542765 has a market cap or net worth of INR 86.11 million. The enterprise value is 87.04 million.
Market Cap | 86.11M |
Enterprise Value | 87.04M |
Important Dates
The next estimated earnings date is Thursday, August 14, 2025.
Earnings Date | Aug 14, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
BOM:542765 has 386,730 shares outstanding.
Current Share Class | 386,730 |
Shares Outstanding | 386,730 |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 74.86% |
Owned by Institutions (%) | 16.67% |
Float | 66,220 |
Valuation Ratios
The trailing PE ratio is 956.73.
PE Ratio | 956.73 |
Forward PE | n/a |
PS Ratio | 104.37 |
PB Ratio | 19.07 |
P/TBV Ratio | 26.46 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 967.06 |
EV / Sales | 105.50 |
EV / EBITDA | 210.23 |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.49, with a Debt / Equity ratio of 0.22.
Current Ratio | 2.49 |
Quick Ratio | 0.45 |
Debt / Equity | 0.22 |
Debt / EBITDA | 2.42 |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 2.01% and return on invested capital (ROIC) is 0.50%.
Return on Equity (ROE) | 2.01% |
Return on Assets (ROA) | 0.39% |
Return on Invested Capital (ROIC) | 0.50% |
Return on Capital Employed (ROCE) | 0.89% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | 5 |
Asset Turnover | 0.12 |
Inventory Turnover | n/a |
Taxes
Income Tax | -48,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -31.54% in the last 52 weeks. The beta is -0.44, so BOM:542765's price volatility has been lower than the market average.
Beta (5Y) | -0.44 |
52-Week Price Change | -31.54% |
50-Day Moving Average | 231.16 |
200-Day Moving Average | 246.38 |
Relative Strength Index (RSI) | 32.48 |
Average Volume (20 Days) | 1,325 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:542765 had revenue of INR 825,000 and earned 90,000 in profits.
Revenue | 825,000 |
Gross Profit | 825,000 |
Operating Income | 42,000 |
Pretax Income | 42,000 |
Net Income | 90,000 |
EBITDA | 414,000 |
EBIT | 42,000 |
Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 73,000 in cash and 1.00 million in debt, giving a net cash position of -930,000 or -2.40 per share.
Cash & Cash Equivalents | 73,000 |
Total Debt | 1.00M |
Net Cash | -930,000 |
Net Cash Per Share | -2.40 |
Equity (Book Value) | 4.52M |
Book Value Per Share | n/a |
Working Capital | 3.44M |
Cash Flow
Operating Cash Flow | -4.46M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of 5.09% and 10.91%.
Gross Margin | 100.00% |
Operating Margin | 5.09% |
Pretax Margin | 5.09% |
Profit Margin | 10.91% |
EBITDA Margin | 50.18% |
EBIT Margin | 5.09% |
FCF Margin | n/a |
Dividends & Yields
BOM:542765 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | 0.10% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |